Vimarsana
Biggest News Aggregation in the World

Page 29 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents to Report Q1 2021 Operating and Financial Results - Vimarsana News

CytoSorbents to Report Q1 2021 Operating and Financial Results

CytoSorbents to Report Q1 2021 Operating and Financial Results News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., April 27, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4:45PM EST.  CytoSorbents' management will host a live conference call and presentation webcast tha...

U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery - Vimarsana News

U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery

Ticagrelor ( STAR-T) randomized, controlled trial.  Based on this conditional approval, study initiation activities, including clinical trial agreement negotiations and institutional review board (IRB) submissions, can now commence, putting the study ahead of the Company's internal schedule.  The Company has already identified and pre-screened many high-quality U.S. clinical centers that have indicated strong interest to participate in the STAR-T trial.  The Company believes conditions for full IDE approval can be appropriately addressed within the 45-day timeframe outlined by the FDA, an...

Breast Cancer Patients Who Drink Non-Diet Soda Have Higher Death Risk - Vimarsana News

Breast Cancer Patients Who Drink Non-Diet Soda Have Higher Death Risk

Breast Cancer Patients Who Drink Non-Diet Soda Have Higher Death Risk Breast cancer patients who drink sugar-sweetened soda regularly are at increased risk for death from any cause and from breast cancer in particular, a new study suggests.   By David Hill-Buffalo Compared to women who never or rarely drank non-diet soda, those who reported drinking non-diet soda five or more times per week had a 62% higher likelihood of dying from any cause, and were 85% more likely to die from breast cancer specifically. Research on soda and breast cancer is fairly new, says study first author Nadia Koyrat...

DVIDS - News - AFSBn-Qatar leadership discuss challenging, successful road to deactivation - Vimarsana News

DVIDS - News - AFSBn-Qatar leadership discuss challenging, successful road to deactivation

5 CAMP AS SAYLIYAH, Qatar – Army Field Support Battalion-Qatar has come a considerable way since first receiving orders to deactivate back in January 2020. As one of five battalions in the 401st Army Field Support Brigade, AFSBn-Qatar had a critical mission during the years of relative instability in the Middle East. Even though the mission has changed, with complete deactivation of the organization scheduled for May, the stakes remain the same. Preceding what is currently being referred to as “Middle East calibration,” AFSBn-Qatar was tasked with receiving, storing, ...

CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference - Vimarsana News

CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference

CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference News provided by Share this article MONMOUTH JUNCTION, N.J., March 12, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Oppenheimer 31 st Annual Healthcare Conference. Chief Executive Officer, Dr. Phillip Chan, MD, PhD will present an overview of the Company's progress and outlook...